{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:53:38Z","timestamp":1762102418988,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18hk0102049s0301"],"award-info":[{"award-number":["18hk0102049s0301"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The 106th Annual Congress of JSS Memorial Surgical Research Fund, Tokyo, Japan","award":["none"],"award-info":[{"award-number":["none"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12876-019-1069-y","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T13:02:39Z","timestamp":1566219759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prior hepatitis B virus infection as a co-factor of chronic hepatitis C patient survival after resection of hepatocellular carcinoma"],"prefix":"10.1186","volume":"19","author":[{"given":"Yutaka","family":"Midorikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadatoshi","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokio","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Moriguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoji","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiko","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,19]]},"reference":[{"key":"1069_CR1","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","volume":"49","author":"G Raimondo","year":"2008","unstructured":"Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49:652\u20137.","journal-title":"J Hepatol"},{"key":"1069_CR2","first-page":"379","volume":"18","author":"Y Matsuzaki","year":"1999","unstructured":"Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, et al. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study. J Exp Clin Cancer Res. 1999;18:379\u201389.","journal-title":"J Exp Clin Cancer Res"},{"key":"1069_CR3","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/jmv.10514","volume":"71","author":"A Tamori","year":"2003","unstructured":"Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, et al. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. J Med Virol. 2003;71:492\u20138.","journal-title":"J Med Virol"},{"key":"1069_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/00365520801935459","volume":"43","author":"S Adachi","year":"2008","unstructured":"Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Scand J Gastroenterol. 2008;43:849\u201356.","journal-title":"Scand J Gastroenterol"},{"key":"1069_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1034\/j.1600-0676.2003.01742.x","volume":"23","author":"E Giannini","year":"2003","unstructured":"Giannini E, Ceppa P, Botta F, Fasoli A, Romagnoli P, Ansaldi F, et al. Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients. Liver Int. 2003;23:12\u20138.","journal-title":"Liver Int"},{"key":"1069_CR6","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1023\/A:1012359400193","volume":"46","author":"S Kubo","year":"2001","unstructured":"Kubo S, Tamori A, Ohba K, Shuto T, Yamamoto T, Tanaka H, et al. Previous or occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma without hepatic fibrosis. Dig Dis Sci. 2001;46:2408\u201314.","journal-title":"Dig Dis Sci"},{"key":"1069_CR7","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1053\/jhep.2000.19288","volume":"32","author":"E Sagnelli","year":"2000","unstructured":"Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T, et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology. 2000;32:1106\u201310.","journal-title":"Hepatology"},{"key":"1069_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.7326\/0003-4819-146-9-200705010-00008","volume":"146","author":"K Ikeda","year":"2007","unstructured":"Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, et al. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study. Ann Intern Med. 2007;146:649\u201356.","journal-title":"Ann Intern Med"},{"key":"1069_CR9","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jhep.2013.05.043","volume":"59","author":"G Squadrito","year":"2013","unstructured":"Squadrito G, Cacciola I, Alibrandi A, Pollicino T, Raimondo G. Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C. J Hepatol. 2013;59:696\u2013700.","journal-title":"J Hepatol"},{"key":"1069_CR10","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.3748\/wjg.v12.i27.4406","volume":"12","author":"A Helmy","year":"2006","unstructured":"Helmy A, Al-Sebayel MI. Isolated antibody to hepatitis B core antigen in patients with chronic hepatitis C virus infection. World J Gastroenterol. 2006;12:4406\u201310.","journal-title":"World J Gastroenterol"},{"key":"1069_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/jmv.21695","volume":"82","author":"M Levast","year":"2010","unstructured":"Levast M, Larrat S, Thelu MA, Nicod S, Plages A, Cheveau A, et al. Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin. J Med Virol. 2010;82:747\u201354.","journal-title":"J Med Virol"},{"key":"1069_CR12","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/hep.21826","volume":"46","author":"S Bruno","year":"2007","unstructured":"Bruno S, Crosignani A, Maisonneuve P, Rossi S, Silini E, Mondelli MU. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology. 2007;46:1350\u20136.","journal-title":"Hepatology"},{"key":"1069_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1478-3231.2005.1096.x","volume":"25","author":"I Hasegawa","year":"2005","unstructured":"Hasegawa I, Orito E, Tanaka Y, Hirashima N, Sakakibara K, Sakurai M, et al. Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-alpha therapy for patients with chronic hepatitis C. Liver Int. 2005;25:247\u201353.","journal-title":"Liver Int"},{"key":"1069_CR14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/hep.24257","volume":"54","author":"AS Lok","year":"2011","unstructured":"Lok AS, Everhart JE, Di Bisceglie AM, Kim HY, Hussain M, Morgan TR, et al. Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. Hepatology. 2011;54:434\u201342.","journal-title":"Hepatology"},{"key":"1069_CR15","doi-asserted-by":"publisher","first-page":"E155","DOI":"10.1111\/hepr.12939","volume":"48","author":"S Itoh","year":"2017","unstructured":"Itoh S, Yoshizumi T, Tomino T, Nagatsu A, Motomura T, Harada N, et al. Associations between antibody to hepatitis B core antigen positivity and outcomes in hepatocellular carcinoma patients undergoing hepatic resection. Hepatol Res. 2017;48:E155\u201361.","journal-title":"Hepatol Res"},{"key":"1069_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jss.2014.07.021","volume":"193","author":"ZF Wu","year":"2015","unstructured":"Wu ZF, Xu Z, Li WS, Zhang HB, Yang N, Yao XQ, et al. Impact of occult hepatitis B virus infection on outcome after resection for non-B non-C hepatocellular carcinoma. J Surg Res. 2015;193:153\u201360.","journal-title":"J Surg Res"},{"key":"1069_CR17","doi-asserted-by":"publisher","first-page":"11931","DOI":"10.3748\/wjg.v21.i42.11931","volume":"21","author":"N Coppola","year":"2015","unstructured":"Coppola N, Onorato L, Pisaturo M, Macera M, Sagnelli C, Martini S, et al. Role of occult hepatitis B virus infection in chronic hepatitis C. World J Gastroenterol. 2015;21:11931\u201340.","journal-title":"World J Gastroenterol"},{"key":"1069_CR18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jhep.2005.01.018","volume":"42","author":"CK Hui","year":"2005","unstructured":"Hui CK, Sun J, Au WY, Lie AK, Yueng YH, Zhang HY, et al. Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. J Hepatol. 2005;42:813\u20139.","journal-title":"J Hepatol"},{"key":"1069_CR19","doi-asserted-by":"publisher","first-page":"21455","DOI":"10.3390\/ijms151121455","volume":"15","author":"S Nakamoto","year":"2014","unstructured":"Nakamoto S, Kanda T, Nakaseko C, Sakaida E, Ohwada C, Takeuchi M, et al. Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t) ide analogues for prevention and treatment. Int J Mol Sci. 2014;15:21455\u201367.","journal-title":"Int J Mol Sci"},{"key":"1069_CR20","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","volume":"27","author":"W Yeo","year":"2009","unstructured":"Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol. 2009;27:605\u201311.","journal-title":"J Clin Oncol"},{"key":"1069_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jhep.2006.10.007","volume":"46","author":"G Raimondo","year":"2007","unstructured":"Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol. 2007;46:160\u201370.","journal-title":"J Hepatol"},{"key":"1069_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00535-009-0020-3","volume":"44","author":"A El-Sherif","year":"2009","unstructured":"El-Sherif A, Abou-Shady M, Abou-Zeid H, Elwassief A, Elbahrawy A, Ueda Y, et al. Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients. J Gastroenterol. 2009;44:359\u201364.","journal-title":"J Gastroenterol"},{"key":"1069_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1515\/CCLM.2010.002","volume":"48","author":"S Urbani","year":"2010","unstructured":"Urbani S, Fagnoni F, Missale G, Franchini M. The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med. 2010;48:23\u20139.","journal-title":"Clin Chem Lab Med"},{"key":"1069_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/hepr.12512","volume":"45","author":"N Kokudo","year":"2015","unstructured":"Kokudo N, Hasegawa K, Akahane M, Igaki H, Izumi N, Ichida T, et al. Evidence-based clinical practice guidelines for hepatocellular carcinoma: the Japan Society of Hepatology 2013 update (3rd JSH-HCC guidelines). Hepatol Res. 2015;45:123\u20137.","journal-title":"Hepatol Res"},{"key":"1069_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ssu.2980090404","volume":"9","author":"M Makuuchi","year":"1993","unstructured":"Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9:298\u2013304.","journal-title":"Semin Surg Oncol"},{"key":"1069_CR26","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00535-013-0841-y","volume":"49","author":"S Yamazaki","year":"2014","unstructured":"Yamazaki S, Takayama T, Nakamura M, Higaki T, Matsuoka S, Mizuno S, et al. Prophylactic impact of endoscopic treatment for esophageal varices in liver resection: a prospective study. J Gastroenterol. 2014;49:917\u201322.","journal-title":"J Gastroenterol"},{"key":"1069_CR27","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1001\/archsurg.136.8.922","volume":"136","author":"T Takayama","year":"2001","unstructured":"Takayama T, Makuuchi M, Kubota K, Harihara Y, Hui AM, Sano K, et al. Randomized comparison of ultrasonic vs clamp transection of the liver. Arch Surg. 2001;136:922\u20138.","journal-title":"Arch Surg"},{"key":"1069_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg"},{"key":"1069_CR29","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0039-6060(99)70089-9","volume":"126","author":"Y Midorikawa","year":"1999","unstructured":"Midorikawa Y, Kubota K, Takayama T, Toyoda H, Ijichi M, Torzilli G, et al. A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery. 1999;126:484\u201391.","journal-title":"Surgery"},{"key":"1069_CR30","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jhep.2012.09.026","volume":"58","author":"Y Midorikawa","year":"2013","unstructured":"Midorikawa Y, Takayama T, Shimada K, Nakayama H, Higaki T, Moriguchi M, et al. Marginal survival benefit in the treatment of early hepatocellular carcinoma. J Hepatol. 2013;58:306\u201311.","journal-title":"J Hepatol"},{"key":"1069_CR31","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S0140-6736(05)70913-2","volume":"365","author":"G Raimondo","year":"2005","unstructured":"Raimondo G, Pollicino T, Squadrito G. What is the clinical impact of occult hepatitis B virus infection? Lancet. 2005;365:638\u201340.","journal-title":"Lancet"},{"key":"1069_CR32","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0140-6736(89)91347-0","volume":"1","author":"S Vento","year":"1989","unstructured":"Vento S, di Perri G, Luzzati R, Garofano T, Concia E, Bassetti D. Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS. Lancet. 1989;1:332\u20133.","journal-title":"Lancet"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-1069-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-019-1069-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-1069-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T23:14:49Z","timestamp":1597706089000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-019-1069-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,19]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1069"],"URL":"https:\/\/doi.org\/10.1186\/s12876-019-1069-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"type":"electronic","value":"1471-230X"}],"subject":[],"published":{"date-parts":[[2019,8,19]]},"assertion":[{"value":"1 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Each participant provided written, informed consent, and this study was approved by the institutional review board of Nihon University (RK-141209-4).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}